Smooth muscle cells in coronary atherosclerotic plaques: Phenotypic variation and clinical consequences

European Journal of Clinical Investigation

Volumn 31, Issue 11, 2001, Pages 923-925

  Van Der Wal, A C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN;

ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE COURSE; FIBROBLAST; HUMAN; MEDICAL SOCIETY; NOTE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE;

EID: 0035780112     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00917.x     Document Type: Note

References (15)

1. Ross R, Glomset J. The pathogenesis of atherosclerosis. N Engl J Med 1972;295:369-77(part 1) and 295:420-8(part 2).
2. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Weissberg PL, Clesham GJ, Bennett M. Is vascular smooth muscle cell proliferation beneficial? Lancet 1996;347:305-6.
4. Gutstein D, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res 1999;41:323-33.
5. van der Wal AC, Becker AE. Atherosclerotic plaque rupture - Pathologic basis of plaque stability and instability. Cardiovasc Res 1999;41:334-44.
6. Mann J, Davies MJ. Mechanisms of progression in native coronary artery sidease. Role of healed plague disruption. Heart 1999;82:265-8.
7. Deuel TF, Bianchi C, Cantley L. Restenosis Injury. A problem in regulation of growth. In: Chien KR, editor. Molecular Basis of Cardiovascular Disease: A Companion to Braunwalds Heart Disease. 1st Edn. Philadelphia: Saunders Company;1999. p.367-39.
8. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans. Microscopic, histological, imuunohistochemical analyses. Circulation 1998;98:224-33.
9. Serruys P, de Jaegere P, Kiemenneij F, Macaya C, Rutsch W, Heyndrickx G et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Eng J Med 1994;331:489-95.
10. Libby P. Molecular bases of acute coronary syndromes. Circulation 1995;91:2844-50.
11. Newby AC. Molecular and cell biology of native coronary artery and veingraft atherosclerosis. Regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions. Coronary Artery Dis 1997;8:213-24.
12. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cyt 1996;169:183-265.
13. Martinez Gonzalez J, Berrozpe M, Varela O, Badimon L. Heterogeneity of smooth muscle cells (SMC) in advanced human atherosclerotic plaques: Intimal SMC expressing a fibroblast surface protein are highly activated by platelet released products. Eur J Clin Invest 2001;31:939-49.
14. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME et al. A definition of advanced types of atherosclerotic lesions and the histological classification of atherosclerosis. A report of the committee on Arterisclerosis, American Heart Association. Circulation 1995;92:1355-74.
15. Esterre P, Melin M, Serrar M, Grimaud JA. New specific markers of human and mouse fibroblasts. Cell Mol Biol 1992;38:297-301.